Inventor · disambiguated record
Thomas H. Mclean
Also filed as: MCLEAN THOMAS H
14 granted patents·12 pending applications·59 citations·filing 2017–2025
92Inventor score
Top patents by PatentIndex Score
26 records- 0196US11220508B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Jan 11, 2022·8 cites·20 claims
- 0294US10323036B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Jun 18, 2019·8 cites·12 claims
- 0393US10562907B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 18, 2020·4 cites·26 claims
- 0491US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 0591US11046698B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Jun 29, 2021·6 cites·12 claims
- 0691US10793574B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Oct 6, 2020·8 cites·12 claims
- 0790US10577373B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Mar 3, 2020·5 cites·28 claims
- 0890US10508120B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Dec 17, 2019·5 cites·30 claims
- 0989US10570145B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 25, 2020·4 cites·26 claims
- 1089US10562906B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 18, 2020·4 cites·28 claims
- 1188US12219327B2Substituted isoindolines as PI3K-alpha inhibitorsRELAY THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·1 cites·6 claims
- 1288US10647713B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted May 12, 2020·4 cites·12 claims
- 1379US2023056447A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 1478US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 1578US2025326760A1Tyk2 inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 1677US2022356184A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 1772US2022073527A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 1866US2025313524A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1965US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2060US11396508B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Jul 26, 2022·0 cites·20 claims
- 2159US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2258US2025388565A1Estrogen receptor alpha degraders and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2357US2024190855A1Cdk inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2456US2025090540A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2554US2025084048A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2654US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas H. Mclean files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →